COVID-19 Vaccine Effectiveness during a Prison Outbreak when Omicron was the Dominant Circulating Variant-Zambia, December 2021.

Simwanza, John; Hines, Jonas Z; Sinyange, Danny; Sinyange, Nyambe; Mulenga, Chilufya; Hanyinza, Sarah; Sakubita, Patrick; Langa, Nelia; Nowa, Haggai; Gardner, Priscilla; Saasa, Ngonda; Chitempa, Graham; Simpungwe, James; Malambo, Warren; Hamainza, Busiku; Chipimo, Peter J; Kapata, Nathan; Kapina, Muzala; Musonda, Kunda; Liwewe, Mazyanga; Mwale, Consity; Fwoloshi, Sombo; Mulenga, Lloyd B; Agolory, Simon; Mukonka, Victor; Chilengi, Roma

Simwanza, John; Hines, Jonas Z; Sinyange, Danny; Sinyange, Nyambe; Mulenga, Chilufya; Hanyinza, Sarah; Sakubita, Patrick; Langa, Nelia; Nowa, Haggai; Gardner, Priscilla; Saasa, Ngonda; Chitempa, Graham; Simpungwe, James; Malambo, Warren; Hamainza, Busiku; Chipimo, Peter J; Kapata, Nathan; Kapina, Muzala; Musonda, Kunda; Liwewe, Mazyanga; Mwale, Consity; Fwoloshi, Sombo; Mulenga, Lloyd B; Agolory, Simon; Mukonka, Victor; Chilengi, Roma.

Affiliation

Simwanza J; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
Hines JZ; National Malaria Elimination Centre, Lusaka, Zambia.
Sinyange D; Centers for Disease Control and Prevention, Lusaka, Zambia.
Sinyange N; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
Mulenga C; National Malaria Elimination Centre, Lusaka, Zambia.
Hanyinza S; Zambia National Public Health Institute, Lusaka, Zambia.
Sakubita P; Zambia Field Epidemiology Training Programme, Lusaka, Zambia.
Langa N; Zambia National Public Health Institute, Lusaka, Zambia.
Nowa H; Zambia National Public Health Institute, Lusaka, Zambia.
Gardner P; Zambia National Public Health Institute, Lusaka, Zambia.
Saasa N; Zambia National Public Health Institute, Lusaka, Zambia.
Chitempa G; Zambia Correctional Services, Lusaka, Zambia.
Simpungwe J; Lusaka Province Health Office, Lusaka, Zambia.
Malambo W; University of Zambia, School of Veterinary Medicine, Department of Disease Control, Lusaka, Zambia.
Hamainza B; Lusaka District Health Office, Lusaka, Zambia.
Chipimo PJ; Centers for Disease Control and Prevention, Lusaka, Zambia.
Kapata N; Centers for Disease Control and Prevention, Lusaka, Zambia.
Kapina M; National Malaria Elimination Centre, Lusaka, Zambia.
Musonda K; Zambia National Public Health Institute, Lusaka, Zambia.
Liwewe M; Zambia National Public Health Institute, Lusaka, Zambia.
Mwale C; Zambia National Public Health Institute, Lusaka, Zambia.
Fwoloshi S; Zambia National Public Health Institute, Lusaka, Zambia.
Mulenga LB; Zambia National Public Health Institute, Lusaka, Zambia.
Agolory S; Lusaka Province Health Office, Lusaka, Zambia.
Mukonka V; Ministry of Health, Lusaka, Zambia.
Chilengi R; Ministry of Health, Lusaka, Zambia.

Am J Trop Med Hyg ; 107(5): 1055-1059, 2022 11 14.

Article de En | MEDLINE | ID: mdl-36096406

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins contre la COVID-19 / COVID-19 Type d'étude: Observational_studies / Risk_factors_studies Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Am J Trop Med Hyg Année: 2022 Type de document: Article Pays d'affiliation: Zambie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google